Middleton, WI, United States of America

Rui Zhu

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Madison, WI (US) (2020 - 2023)
  • Middleton, WI (US) (2019 - 2024)
  • San Diego, CA (US) (2022 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Celebrating the Innovations of Inventor Rui Zhu

Introduction

Rui Zhu is a distinguished inventor based in Middleton, WI, with an impressive portfolio of 15 patents to his name. His pioneering work primarily focuses on cutting-edge RNA interference (RNAi) technologies and their applications in treating various diseases, notably renal cell carcinomas. Through his innovative contributions, Zhu has made significant strides in the medical field.

Latest Patents

Among his latest patents, Rui Zhu has developed RNAi agents designed to inhibit the expression of the HIF-2 alpha gene. This invention encompasses novel double-stranded RNAi agents that can effectively target HIF-2 alpha (EPAS1) gene expression. The disclosure also covers pharmaceutical compositions containing these RNAi agents, which may be enhanced by targeting ligands that interact with integrins, enabling better delivery to cells, specifically targeting clear cell renal cell carcinoma (ccRCC) tumors. Furthermore, Zhu has patented prekallikrein-modulating compositions, which offer methods for altering the expression or activity of plasma prekallikrein. This innovation may help reduce PKK mRNA and protein levels in cells, presenting therapeutic potentials in related health conditions.

Career Highlights

Rui Zhu's career includes key positions at notable biotechnology firms, including Arrowhead Pharmaceuticals, Inc. and Adarx Pharmaceuticals, Inc. His work in these companies has furthered the development of RNAi technologies and other pharmaceutical innovations.

Collaborations

Throughout his professional journey, Rui Zhu has collaborated with talented coworkers, such as Zhen Li and Tao Pei. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and the development of groundbreaking solutions in the field of biomedicine.

Conclusion

Rui Zhu's contributions to the realm of medical research and biotechnology through his 15 patents mark him as an influential figure in the industry. His innovative advancements in RNAi agents and modulatory compositions stand to benefit numerous patients suffering from serious health conditions. As he continues to pave the way for future inventions, the impact of his work will undoubtedly shape the future of therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…